We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns Boston’s TEI Biosciences Over ‘Systemic’ Quality Failures
FDA Warns Boston’s TEI Biosciences Over ‘Systemic’ Quality Failures
The FDA issued a warning letter to TEI Biosciences’ for “systemic” quality failures the agency found during an Oct. 9 to Nov. 2, 2018, inspection of its Boston, Mass., facility.